Considering the evidence from the trial showed no benefit in adults, I'd suspect we would need a different trial, no?
Or are we just forgoing evidence based medicine in favour of the shareholders these days?
banter and General Discussion, page-6906
-
- There are more pages in this discussion • 3,591 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
0.015(1.62%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $3.514M | 3.684M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 172250 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.0¢ | 48283 | 21 |
View Market Depth
| Last trade - 15.00pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |